CLINICAL_TRIALS
trial_result
· 2022-10-31
Clinical Trial Update: Eptinezumab in Adults With Migraine and Medication Overuse Headache [Phase 3]
Summary
Phase 3 trial update for eptinezumab in adults with migraine and medication overuse headache has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: H. Lundbeck A/S | Conditions: Migraine, Medication Overuse Headache | Phase 3 | Status: COMPLETED